THE GLOBAL LATERAL FLOW ASSAYS MARKET IS EXPECTED TO REACH USD 11.30 BILLION BY 2028 FROM USD 9.53 BILLION IN 2022, GROWING AT A CAGR OF 2.89% DURING THE FORECAST PERIOD

The Lateral Flow Assays Market Size, Share, & Trends Analysis Report By

  • Product: Kits & Reagents and Readers
  • Application: Clinical Diagnostics, Food Safety, Veterinary Diagnostics, and Others
  • Technique: Sandwich Assays and Competitive Assays
  • End-Users: Hospitals & Clinics, Individuals, Diagnostic Laboratories, Food & Beverage Companies, Pharma & Biotech Companies, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

310 Pages

icon-table

146 Tables

icon-chart

141 Charts

icon-region

5 Regions

icon-country

20 Countries

icon-company

37 Companies

icon-market

5 Market Segment

LATERAL FLOW ASSAYS MARKET REPORT SCOPE

Report Attribute Details
Market Size (2028) USD 11.30 Billion
Market Size (2022) USD 9.53 Billion
CAGR (2022-2028) 2.89%
Base Year 2022
Forecast Year 2023-2028
Market Segments Product, Application, Technique, End-Users, and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORS Abbott, F. Hoffmann-La Roche, Danaher, Siemens Healthineers, and Danaher

MARKET OVERVIEW

The global lateral flow assays market was valued at USD 9.53 billion in 2022 and is expected to reach USD 11.30 billion by 2028, growing at a CAGR of 2.89%. The market is one of the major segments in the global point of care or the rapid diagnostics market and is growing steadily and is anticipated to grow at a similar pace during the forecast period. Further, the growth in the market is attributed to the increasing prevalence/incidence of various infectious and chronic diseases. In addition, malaria is still a cause of death in a few regions. For instance, according to the WHO, malaria is one of the leading causes of death in the Middle East & Africa.

Moreover, the general population, especially the elderly and children, require periodic health checkups for seasonal flu during monsoon and winter, collectively fueling the rapid diagnostics market. In addition, the Covid-19 pandemic has positively impacted the market with a surge in demand for rapid Covid-19 tests. Countries like the UK, Germany, France, Russia, and the USA plan to perform mass testing to screen their country population and take necessary steps to prevent the spread of the disease. Such factors have increased the demand for rapid test kits globally. Rapid testing plays a significant role in monitoring the pandemic situation. Furthermore, increased use of diagnostics tests for various purposes, such as routine health checkups, infectious diseases, seasonal flu, blood donation, blood preservations, and blood transfusion, boosts the lateral flow assay market.

Lateral Flow Assays Market Report

MARKET TRENDS & OPPORTUNITIES

Smartphone and AI Integration in Lateral Flow Immunoassay
The use of smartphones as biosensors in many applications (e.g., optical-based methods such as absorption, reflection, fluorescence, etc.) is particularly important for improving diagnostics, healthcare, medical, food, and environmental monitoring. It has the potential as a portable, low-cost POC platform and provides treatment in remote low-income areas. The Cambridge-based startup, PocDoc, has received CE mark approval for a digital reader powered with artificial intelligence (AI) for lateral flow testing. The cloud-based system turns any smartphone or tablet into a universal digital reader, enabling healthcare organizations to perform large-scale lateral flow testing for any disease or marker. An AI-driven innovation that can read a COVID-19 lateral flow diagnostic test using a user's smartphone has received special use approval from the Medicines and Healthcare Products Regulatory Agency (MHRA).

Evolving New Application of Lateral Flow Assays

Lateral flow testing is widely used for infectious disease diagnosis, heart disease diagnosis, and veterinary applications but has seen increased use in recent years in several new applications. For example, saliva diagnostics, behavioral health, agriculture (detection of genetically modified organisms and quality control of plants), biological warfare (detection of Bacillus anthracis), environmental testing (detection of contaminating enzymes in production facilities), food microbiology (E. coli Detection of O157, Salmonella, Listeria, and other food spoilage bacteria) has emerged as a new application area in the lateral flow assays market.

Saliva is a new biological fluid with many studies and clinical applications. OraSure Technologies, based in the US, is one of the largest lateral flow saliva testing vendors. Salivary LFAs have also infiltrated the market for applications such as substance abuse testing, and several systems have been cleared for sale by the FDA. However, the tests remain largely qualitative.

Growing Adoption of Home-Based Lateral Flow Assay Devices
Home tests (also called self-tests or home tests) are typically sold over the counter and allow users to test self-collected samples and obtain results without the assistance of a trained medical professional. The home-use lateral flow assay device plays an important role in the treatment of cardiovascular disease and infectious diseases. These devices could also be very useful for testing pregnancy and stigmatized diseases such as HIV, allowing patients to perform self-tests at home. Therefore, the increasing incidence of these diseases and the growing adoption of lateral flow assay testing in home healthcare are expected to propel the lateral flow assays market growth. During COVID-19, many companies have introduced at-home lateral flow assays for COVID-19 testing. This is because people feared rushing to a diagnostic lab or hospital for testing has created a demand for at-home lateral flow assays. Some of the introduced tests for home use were:

  • In August 2020, BinaxNOW COVID-19 Ag Card and Panbio rapid COVID-19 test in September 2020
  • In September 2020, Roche launched the SARS-CoV-2 Rapid Antigen test
  • Quidel launched during the COVID-19, Sofia 2 Flu+ SARS Antigen FIA
  • In June 2022, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen test and
  • BD has launched the BD Veritor SARS CoV-2 Test

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT
The kits & reagents are expected to be the largest product segment in the global lateral flow assays market in 2022, accounting for a share of 82.24%. These kits & reagents predominantly include biomarkers, assay kits, and reagents, including substrates, enzymes, specific proteins, lipids, and other test kits. The awareness of rapid and POC testing for various infectious diseases is one of the key factors driving the demand for rapid testing. The large market share of the segment is also attributed to the use of consumables reoccurring in nature, and the consumables segment generates continuous revenue for vendors. As a result, many renowned vendors are manufacturing consumables required for analyzers. This growth is attributable to the growing use of rapid tests in several points of care (POC) sites, such as emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing several diseases such as infectious diseases, diabetes, cancer, and other metabolic diseases.

INSIGHTS BY APPLICATION
The global lateral flow assays market is segmented into clinical diagnostics, food safety, veterinary diagnostics, and others. Clinical application accounted for the global market's highest share, 46.50%, in 2022. Rapid infectious disease diagnostic tests are critical for diagnosing diseases for early detection and biosurveillance and improving global health. For instance, the Health and Human Services (HHS), the National Institutes of Health (NIH), the US Centers for Disease Control and Prevention (CDC), and the US Department of Defense (DoD) consider rapid and early detection a keyway to reduce the impact on the population. The POC provides multiple advantages over other diagnostics to diagnose infectious diseases, especially for rapid testing scenarios. For instance, Chembio, a leading lateral flow assay market company, is offering FDA-approved LFA HIV tests, SURE CHECK HIV 1/2 Assay, which combines a patented plastic "barrel" device that houses the lateral flow strip.

The global lateral flow assays market by food safety is expected to reach USD 3.83 billion by 2028. The lateral flow test is a very convenient immunoassay for detecting foodborne pathogens. The test covers the most important pathogens, acts as a minilab, and includes built-in control reactions for optimized pathogen testing. There are many leading and local players offering LFA testing for food testing, including Sigma-Aldrich, a subsidiary of Merck kGaA, Perkinelmer, R- Biopharma, Abingdon Health, and creative diagnostics.

INSIGHTS BY TECHNIQUE
The sandwich assays held the most significant technique segment share in the global lateral flow assays market in 2022 at 61.36%. The first type of LFA assay is a non-competitive or sandwich assay. It is used for macromolecular analytes with two antigen-binding sites: which bind to the target and has a binder that does not interfere with each other. If the target is present in the sample, the signal at the test line will increase. The LFA vendor uses the sandwich technique to market their product; the best-known examples of this format are the over-the-counter pregnancy tests. The sandwich assays account for a larger share of the technique segment, also growing with a high growth rate of 3.39% in the market. At the same time, the competitive segment accounted for 38.64% of the global lateral flow assays market.

INSIGHTS BY END USERS
The global lateral flow assays market is segmented into hospitals & clinics, individuals, diagnostic laboratories, food & beverage companies (FBC), pharma & biotech companies (PBC), and others by end-users. The hospitals & clinics held the largest end-users market share at 25.32% in 2022. Hospitals perform more rapid tests than other end-users and form the first point of contact for infections and diseases. The diagnosis is used for the initial patient screening, thereby contributing to the larger use of rapid testing in hospitals. Moreover, hospitals establish contracts with multiple vendors for procuring rapid test kits, POC analyzers, and related consumables. In addition, hospital laboratories are unique entities in hospitals. Around 92% of the hospitals operate with their laboratories. Hospitals are one of the largest end-users of infectious disease diagnosis, which perform a wide range of diagnostics per the requirement.

The global lateral flow assays market by individuals was valued at USD 1.87 billion in 2022. Initially, home care settings were introduced to reduce hospital resource utilization for longer periods. This became popular, and the demand for home care has gone high. The demand is extremely high in developed countries. The aged population is increasing globally, and usage of blood glucose monitoring and other tests is increasing across the home care segment. With the usage of rapid testing, there are multiple advantages to home health care providers. This provides rapid turnaround times, improved decision times, and time-critical decision-making can result in total savings between 8-20% of laboratory costs.

GEOGRAPHICAL INSIGHTS

North America accounted for the highest share of 28.57% in the global lateral flow assays market in 2022. The region is dominating among all the regions due to several factors, such as the increase in the prevalence of infectious diseases such as COVID-19, influenza, HIV, chronic conditions & lifestyle diseases, easy availability, and the high affordability of technologically advanced LFAs, presence of key vendor for the LFAs. Moreover, the presence of advanced healthcare infrastructure and the availability of government funding for research will likely augment the expansion of the LFA market for LFAs in this region. For instance, In July 2020, the NIH invested USD 248.7 million in developing new technologies to deal with the challenges associated with the testing of COVID-19.

Europe's lateral flow assays market was valued at USD 2.58 billion in 2022. The region has developed healthcare infrastructure with the availability of advanced lateral flow assay devices coupled with the high prevalence of infectious and chronic diseases, which has significantly contributed to the overall growth of the lateral flow assay market. Moreover, the region is affected by the increasing prevalence of infectious diseases, which include HIV, Haemophilus influenzae, Meningococcal disease, Streptococcus pneumoniae, etc., contributing to the growth of the market.

The APAC lateral flow assays market is expected to register the fastest growth rate in the global market at a CAGR of 3.90% during the forecast period. Developing countries comprise 84% of the world's population, and Asia accounts for about 60%, making it one of the significant contributors. The incidence of communicable and non-communicable diseases such as diabetes, obesity, cardiovascular disease, and cancer is increasing much faster in developing countries than in developed countries. About 4.3 million people die each year in developing countries from acute respiratory infections, 1 million from malaria, and about 5 million from AIDS and tuberculosis. In 2013, about 8 million people in these countries died from non-communicable diseases before her 60th birthday. Developing countries continue to struggle to meet the challenges of diseases that are preventable and treatable in developed countries.

VENDOR LANDSCAPE

The global lateral flow assay market is highly dynamic, with several global and local players offering various instruments/analyzers and reagents for diagnosing various clinical testing, food safety, Veterinary Diagnostics, drug testing, etc. The industry is consolidated with global players accounting for dominant shares. Abbott, Danaher, F. Hoffmann-La Roche, Quidel, and Siemens Healthineers are the leading players and account for significant global lateral flow assays market share.

Global players focus on developing technologically advanced diagnoses and enlarging their product portfolio to remain competitive. The companies are investing extensively in R&D and product development activities to expand their product portfolio. Manufacturers such as Abbott, F. Hoffmann-La Roche, Danaher, Quidel, and Siemens Healthineers are continuously focusing on product development and offering diagnostics with new technology to increase their market presence. Merck, a leading science and technology company, has broken ground today at its first US lateral flow membrane manufacturing facility in Sheboygan, Wisconsin. Lateral flow membranes are a key component of rapid diagnostic test kits for various applications, including Covid-19 testing. The new facility is backed by his USD 128 million contract award from the US Department of Defense (DoD) on behalf of the US Department of Health and Human Services.

Frequently Asked Questions

How big is the lateral flow assays market?

The global lateral flow assays market size was valued at USD 9.53 billion in 2022 and is expected to reach USD 11.30 billion by 2028.

What is the growth rate of the lateral flow assays market?

The global lateral flow assays market share is growing at a CAGR of 2.89% from 2022-2028.

Which are the key companies in the global lateral flow assays market?

Abbott, F. Hoffmann-La Roche, Danaher, Siemens Healthineers, and Danaher are the key vendors in the global lateral flow assays market.

Which region holds the most significant global lateral flow assays market share?

North America dominates the global lateral flow assays market with a 28.57% share.

What are the rising trends in the lateral flow assay market?

Smartphone and AI integration in lateral flow immunoassay, evolving new applications of lateral flow assays, and a surge in demand for lateral flow assays in the food & beverage industry are the growing trends in the global lateral flow assays market.

Download Free Sample

The lateral flow assays market is expected to grow at a CAGR of approximately 2.89% from 2022 to 2028.

The following factors are likely to contribute to the growth of the global lateral flow assays market during the forecast period:

  • Rising Prevalence of Chronic and Infectious Diseases
  • Growing Adoption of Home-Based Lateral Flow Assay Devices
  • Growing Demand for Point-Of-Care Testing

Base Year: 2022

Forecast Year: 2023-2028

The report considers the present scenario of the lateral flow assays market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.

Key Company Profiles

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Quidel

Other Prominent Vendors

  • BD
    • Business Overview
    • Product Offerings
  • Abaxis
  • Abingdon Health
  • Access BIO
  • Arbor Vita
  • Assure Tech
  • Atomo Diagnostics
  • AccuBioTech
  • BIOMÉRIEUX
  • bioLytical Laboratories
  • BIO-RAD Laboratories
  • Biosynex
  • Cupid
  • DIALAB
  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH
  • INTEC
  • J. Mitra & Co. Pvt. Ltd.
  • Meril Life Sciences
  • MP Biomedicals
  • Medsource Ozone Biomedicals
  • Nanjing Synthgene Medical Technology
  • OraSure Technologies
  • Premier Medical
  • QIAGEN
  • SD Biosensor
  • Rega Biotechnology
  • KHB
  • Türklab A.S.
  • Trinity Biotech
  • Wondfo
  • PerkinElmer
  • Merck KGaA

Segmentation by Product

  • Kits & Reagents
  • Readers

Segmentation by Application

  • Clinical Diagnostics
  • Food Safety
  • Veterinary Diagnostics
  • Others

Segmentation by Technique

  • Sandwich Assays
  • Competitive Assays

Segmentation by End-Users

  • Hospitals & Clinics
  • Individuals
  • Diagnostic Laboratories
  • Food & Beverage Companies
  • Pharma & Biotech Companies
  • Others

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Russia
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Philippines
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

6.1 MARKET OVERVIEW

6.1.1 MARKET DYNAMICS

6.1.2 MARKET SEGMENTATION

6.1.3 VENDOR ANALYSIS

7 MARKET AT A GLANCE

8 INTRODUCTION

8.1 OVERVIEW

9 MARKET OPPORTUNITIES & TRENDS

9.1 SMARTPHONE & ARTIFICIAL INTELLIGENCE INTEGRATION IN LATERAL FLOW IMMUNOASSAY

9.2 NEW APPLICATIONS OF LFAS

9.3 SURGE IN DEMAND FOR LFAS IN FOOD & BEVERAGE INDUSTRY

10 MARKET GROWTH ENABLERS

10.1 PREVALENCE OF CHRONIC & INFECTIOUS DISEASES

10.2 ADOPTION OF HOME-BASED LFA DEVICES

10.3 DEMAND FOR POC TESTING

11 MARKET RESTRAINTS

11.1 AVAILABILITY OF ALTERNATIVE TESTING APPROACHES

11.2 INCONSISTENT RESULTS & LIMITATIONS OF LFA TESTS

11.3 CHALLENGES IN RAW MATERIAL SOURCING & LFA DEVELOPMENT

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHT BY GEOGRAPHY SEGMENTATION

12.2.2 INSIGHT BY PRODUCT SEGMENTATION

12.2.3 INSIGHT BY TECHNIQUE SEGMENTATION

12.2.4 INSIGHT BY APPLICATION SEGMENTATION

12.2.5 INSIGHT BY END-USER SEGMENTATION

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

13 PRODUCT

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 KITS & REAGENTS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 MARKET BY GEOGRAPHY

13.4 READERS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

14 APPLICATION

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 CLINICAL DIAGNOSTICS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 FOOD SAFETY

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 VETERINARY DIAGNOSTICS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 OTHERS

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

15 TECHNIQUE

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 SANDWICH ASSAYS

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 COMPETITIVE ASSAYS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 HOSPITALS & CLINICS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.3.3 MARKET BY GEOGRAPHY

16.4 HOME HEALTHCARE

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.4.3 MARKET BY GEOGRAPHY

16.5 DIAGNOSTIC LABORATORIES

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.5.3 MARKET BY GEOGRAPHY

16.6 FOOD & BEVERAGE COMPANIES

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.6.3 MARKET BY GEOGRAPHY

16.7 PHARMA & BIOTECH COMPANIES

16.7.1 MARKET OVERVIEW

16.7.2 MARKET SIZE & FORECAST

16.7.3 MARKET BY GEOGRAPHY

16.8 OTHERS

16.8.1 MARKET OVERVIEW

16.8.2 MARKET SIZE & FORECAST

16.8.3 MARKET BY GEOGRAPHY

17 GEOGRAPHY

17.1 MARKET SNAPSHOT & GROWTH ENGINE

17.2 GEOGRAPHIC OVERVIEW

18 NORTH AMERICA

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 NORTH AMERICA: PRODUCT SEGMENTATION

18.4 NORTH AMERICA: APPLICATION SEGMENTATION

18.5 NORTH AMERICA: TECHNIQUE SEGMENTATION

18.6 NORTH AMERICA: END-USER SEGMENTATION

18.7 KEY COUNTRIES

18.7.1 US: MARKET SIZE & FORECAST

18.7.2 CANADA: MARKET SIZE & FORECAST

19 EUROPE

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 EUROPE: PRODUCT SEGMENTATION

19.4 EUROPE: APPLICATION SEGMENTATION

19.5 EUROPE: TECHNIQUE SEGMENTATION

19.6 EUROPE: END-USER SEGMENTATION

19.7 KEY COUNTRIES

19.7.1 UK: MARKET SIZE & FORECAST

19.7.2 FRANCE: MARKET SIZE & FORECAST

19.7.3 GERMANY: MARKET SIZE & FORECAST

19.7.4 ITALY: MARKET SIZE & FORECAST

19.7.5 RUSSIA: MARKET SIZE & FORECAST

19.7.6 SPAIN: MARKET SIZE & FORECAST

20 APAC

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 APAC: PRODUCT SEGMENTATION

20.4 APAC: APPLICATION SEGMENTATION

20.5 APAC: TECHNIQUE SEGMENTATION

20.6 APAC: END-USER SEGMENTATION

20.7 KEY COUNTRIES

20.7.1 INDIA: MARKET SIZE & FORECAST

20.7.2 CHINA: MARKET SIZE & FORECAST

20.7.3 JAPAN: MARKET SIZE & FORECAST

20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST

20.7.5 AUSTRALIA: MARKET SIZE & FORECAST

20.7.6 PHILIPPINES: MARKET SIZE & FORECAST

21 LATIN AMERICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 LATIN AMERICA: PRODUCT SEGMENTATION

21.4 LATIN AMERICA: APPLICATION SEGMENTATION

21.5 LATIN AMERICA: TECHNIQUE SEGMENTATION

21.6 LATIN AMERICA: END-USER SEGMENTATION

21.7 KEY COUNTRIES

21.7.1 BRAZIL: MARKET SIZE & FORECAST

21.7.2 MEXICO: MARKET SIZE & FORECAST

21.7.3 ARGENTINA: MARKET SIZE & FORECAST

22 MIDDLE EAST & AFRICA

22.1 MARKET OVERVIEW

22.2 MARKET SIZE & FORECAST

22.3 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

22.4 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

22.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION

22.6 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

22.7 KEY COUNTRIES

22.7.1 TURKEY: MARKET SIZE & FORECAST

22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST

22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST

23 COMPETITIVE LANDSCAPE

23.1 COMPETITION OVERVIEW

23.2 MARKET SHARE ANALYSIS

24 KEY COMPANY PROFILES

24.1 ABBOTT

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.1.3 KEY STRATEGIES

24.1.4 KEY STRENGTHS

24.1.5 KEY OPPORTUNITIES

24.2 F. HOFFMANN-LA ROCHE

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.2.3 KEY STRATEGIES

24.2.4 KEY STRENGTHS

24.2.5 KEY OPPORTUNITIES

24.3 SIEMENS HEALTHINEERS

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.3.3 KEY STRATEGIES

24.3.4 KEY STRENGTHS

24.3.5 KEY OPPORTUNITIES

24.4 THERMO FISHER SCIENTIFIC

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.4.3 KEY STRATEGIES

24.4.4 KEY STRENGTHS

24.4.5 KEY OPPORTUNITIES

24.5 QUIDEL

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERINGS

24.5.3 KEY STRATEGIES

24.5.4 KEY STRENGTHS

24.5.5 KEY OPPORTUNITIES

25 OTHER PROMINENT VENDORS

25.1 ABAXIS

25.1.1 BUSINESS OVERVIEW

25.1.2 PRODUCT OFFERINGS

25.2 ABINGDON HEALTH

25.2.1 BUSINESS OVERVIEW

25.2.2 PRODUCT OFFERINGS

25.3 ACCESS BIO

25.3.1 BUSINESS OVERVIEW

25.3.2 PRODUCT OFFERINGS

25.4 ARBOR VITA

25.4.1 BUSINESS OVERVIEW

25.4.2 PRODUCT OFFERINGS

25.5 ASSURE TECH

25.5.1 BUSINESS OVERVIEW

25.5.2 PRODUCT OFFERINGS

25.6 ATOMO DIAGNOSTICS

25.6.1 BUSINESS OVERVIEW

25.6.2 PRODUCT OFFERINGS

25.7 ACCUBIOTECH

25.7.1 BUSINESS OVERVIEW

25.7.2 PRODUCT OFFERINGS

25.8 BD

25.8.1 BUSINESS OVERVIEW

25.8.2 PRODUCT OFFERINGS

25.9 BIOMÉRIEUX

25.9.1 BUSINESS OVERVIEW

25.9.2 PRODUCT OFFERINGS

25.1 BIOLYTICAL LABORATORIES

25.10.1 BUSINESS OVERVIEW

25.10.2 PRODUCT OFFERINGS

25.11 BIO-RAD LABORATORIES

25.11.1 BUSINESS OVERVIEW

25.11.2 PRODUCT OFFERINGS

25.12 BIOSYNEX

25.12.1 BUSINESS OVERVIEW

25.12.2 PRODUCT OFFERINGS

25.13 CUPID

25.13.1 BUSINESS OVERVIEW

25.13.2 PRODUCT OFFERINGS

25.14 DIALAB

25.14.1 BUSINESS OVERVIEW

25.14.2 PRODUCT OFFERINGS

25.15 HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH

25.15.1 BUSINESS OVERVIEW

25.15.2 PRODUCT OFFERINGS

25.16 INTEC

25.16.1 BUSINESS OVERVIEW

25.16.2 PRODUCT OFFERINGS

25.17 J. MITRA & CO. PVT.LTD.

25.17.1 BUSINESS OVERVIEW

25.17.2 PRODUCT OFFERINGS

25.18 KHB

25.18.1 BUSINESS OVERVIEW

25.18.2 PRODUCT OFFERINGS

25.19 MERIL LIFE SCIENCES

25.19.1 BUSINESS OVERVIEW

25.19.2 PRODUCT OFFERINGS

25.20 MERCK KGAA

25.20.1 BUSINESS OVERVIEW

25.20.2 PRODUCT OFFERINGS

25.21 MP BIOMEDICALS

25.21.1 BUSINESS OVERVIEW

25.21.2 PRODUCT OFFERINGS

25.22 MEDSOURCE OZONE BIOMEDICALS

25.22.1 BUSINESS OVERVIEW

25.22.2 PRODUCT OFFERINGS

25.23 NANJING SYNTHGENE MEDICAL TECHNOLOGY

25.23.1 BUSINESS OVERVIEW

25.23.2 PRODUCT OFFERINGS

25.24 ORASURE TECHNOLOGIES

25.24.1 BUSINESS OVERVIEW

25.24.2 PRODUCT OFFERINGS

25.25 PERKINELMER

25.25.1 BUSINESS OVERVIEW

25.25.2 PRODUCT OFFERINGS

25.26 PREMIER MEDICAL

25.26.1 BUSINESS OVERVIEW

25.26.2 PRODUCT OFFERINGS

25.27 QIAGEN

25.27.1 BUSINESS OVERVIEW

25.27.2 PRODUCT OFFERINGS

25.28 REGA BIOTECHNOLOGY

25.28.1 BUSINESS OVERVIEW

25.28.2 PRODUCT OFFERINGS

25.29 SD BIOSENSOR

25.29.1 BUSINESS OVERVIEW

25.29.2 PRODUCT OFFERINGS

25.30 TÜRKLAB A.S.

25.30.1 BUSINESS OVERVIEW

25.30.2 PRODUCT OFFERINGS

25.31 TRINITY BIOTECH

25.31.1 BUSINESS OVERVIEW

25.31.2 PRODUCT OFFERINGS

25.32 WONDFO

25.32.1 BUSINESS OVERVIEW

25.32.2 PRODUCT OFFERINGS

26 REPORT SUMMARY

26.1 KEY TAKEAWAYS

26.2 STRATEGIC RECOMMENDATIONS

27 QUANTITATIVE SUMMARY

27.1 MARKET BY PRODUCT

27.1.1 NORTH AMERICA: PRODUCT SEGMENTATION

27.1.2 EUROPE: PRODUCT SEGMENTATION

27.1.3 APAC: PRODUCT SEGMENTATION

27.1.4 LATIN AMERICA: PRODUCT SEGMENTATION

27.1.5 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION

27.2 MARKET BY TECHNIQUE

27.2.1 NORTH AMERICA: TECHNIQUE SEGMENTATION

27.2.2 EUROPE: TECHNIQUE SEGMENTATION

27.2.3 APAC: TECHNIQUE SEGMENTATION

27.2.4 LATIN AMERICA: TECHNIQUE SEGMENTATION

27.2.5 MIDDLE EAST & AFRICA: TECHNIQUE SEGMENTATION

27.3 MARKET BY APPLICATION

27.3.1 NORTH AMERICA: APPLICATION SEGMENTATION

27.3.2 EUROPE: APPLICATION SEGMENTATION

27.3.3 APAC: APPLICATION SEGMENTATION

27.3.4 LATIN AMERICA: APPLICATION SEGMENTATION

27.3.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

27.4 MARKET BY END-USER

27.4.1 NORTH AMERICA: END-USER SEGMENTATION

27.4.2 EUROPE: END-USER SEGMENTATION

27.4.3 APAC: END-USER SEGMENTATION

27.4.4 LATIN AMERICA: END-USER SEGMENTATION

27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

27.5 MARKET BY GEOGRAPHY

27.5.1 KITS & REAGENTS: GEOGRAPHY SEGMENTATION

27.5.2 READERS: GEOGRAPHY SEGMENTATION

27.5.3 CLINICAL DIAGNOSTICS: GEOGRAPHY SEGMENTATION

27.5.4 FOOD SAFETY: GEOGRAPHY SEGMENTATION

27.5.5 VETERINARY DIAGNOSTICS: GEOGRAPHY SEGMENTATION

27.5.6 OTHERS: GEOGRAPHY SEGMENTATION

27.5.7 SANDWICH ASSAYS: GEOGRAPHY SEGMENTATION

27.5.8 COMPETITIVE ASSAYS: GEOGRAPHY SEGMENTATION

27.5.9 HOSPITALS & CLINICS: GEOGRAPHY SEGMENTATION

27.5.10 HOME HEALTHCARE: GEOGRAPHY SEGMENTATION

27.5.11 DIAGNOSTIC LABORATORIES: GEOGRAPHY SEGMENTATION

27.5.12 FOOD & BEVERAGE COMPANIES: GEOGRAPHY SEGMENTATION

27.5.13 PHARMA & BIOTECH COMPANIES: GEOGRAPHY SEGMENTATION

27.5.14 OTHERS: GEOGRAPHY SEGMENTATION

28 APPENDIX

28.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL LATERAL FLOW ASSAY MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022

EXHIBIT 3 GLOBAL LATERAL FLOW ASSAY MARKET: 2022 & 2028 ($ BILLION)

EXHIBIT 4 GLOBAL LATERAL FLOW ASSAY MARKET: SEGMENTATION

EXHIBIT 5 IMPACT OF SMARTPHONE & ARTIFICIAL INTELLIGENCE INTEGRATION IN LATERAL FLOW IMMUNOASSAY

EXHIBIT 6 IMPACT OF NEW APPLICATIONS OF LFAS

EXHIBIT 7 IMPACT OF SURGE IN DEMAND FOR LFAS IN FOOD & BEVERAGE INDUSTRY

EXHIBIT 8 ADVANTAGES OF LFA TESTS IN FOOD & BEVERAGE INDUSTRY

EXHIBIT 9 IMPACT OF PREVALENCE OF CHRONIC & INFECTIOUS DISEASES

EXHIBIT 10 GLOBAL INFECTIOUS DISEASE STATISTICS

EXHIBIT 11 IMPACT OF ADOPTION OF HOME-BASED LFA DEVICES

EXHIBIT 12 IMPACT OF DEMAND FOR POC TESTING

EXHIBIT 13 ADVANTAGES OF RAPID/POC TESTS

EXHIBIT 14 IMPACT OF AVAILABILITY OF ALTERNATIVE TESTING APPROACHES

EXHIBIT 15 ALTERNATIVE APPROACHES TO LATERAL FLOW TESTING

EXHIBIT 16 IMPACT OF INCONSISTENT RESULTS & LIMITATIONS OF LFA TESTS

EXHIBIT 17 LIMITATIONS OF LFA TESTS

EXHIBIT 18 IMPACT OF CHALLENGES IN RAW MATERIAL SOURCING & LFA DEVELOPMENT

EXHIBIT 19 GLOBAL LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)

EXHIBIT 20 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY

EXHIBIT 21 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT

EXHIBIT 22 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE

EXHIBIT 23 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION

EXHIBIT 24 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER

EXHIBIT 25 FIVE FORCES ANALYSIS 2022

EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 27 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT

EXHIBIT 28 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT: INCREMENTAL GROWTH

EXHIBIT 29 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 30 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)

EXHIBIT 31 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 32 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)

EXHIBIT 33 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 34 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION

EXHIBIT 35 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 36 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION: ABSOLUTE GROWTH

EXHIBIT 37 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS 2022–2028 ($ BILLION)

EXHIBIT 39 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 40 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)

EXHIBIT 41 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)

EXHIBIT 43 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 44 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

EXHIBIT 45 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 46 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE

EXHIBIT 47 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE: INCREMENTAL GROWTH

EXHIBIT 48 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE: ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)

EXHIBIT 51 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 54 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER

EXHIBIT 55 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 56 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 57 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 58 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)

EXHIBIT 59 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 60 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)

EXHIBIT 61 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)

EXHIBIT 63 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 64 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)

EXHIBIT 65 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 66 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)

EXHIBIT 67 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

EXHIBIT 69 INCREMENTAL GROWTH BY GEOGRAPHY (2022 & 2028)

EXHIBIT 70 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY

EXHIBIT 71 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 72 LATERAL FLOW ASSAY MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 73 NORTH AMERICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)

EXHIBIT 74 NORTH AMERICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 75 NORTH AMERICA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 76 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 77 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 78 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 79 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA (2022 & 2028)

EXHIBIT 81 US INFECTIOUS DISEASE STATISTICS

EXHIBIT 82 US LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 83 CANADA INFECTIOUS DISEASE STATISTICS

EXHIBIT 84 CANADA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 85 EUROPE LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)

EXHIBIT 86 EUROPE LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 87 EUROPE LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 88 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 89 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 90 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 91 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 92 INCREMENTAL GROWTH IN EUROPE (2022 & 2028)

EXHIBIT 93 UK LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 94 FRANCE LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 95 GERMANY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 96 ITALY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 97 RUSSIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 98 SPAIN LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 99 APAC LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)

EXHIBIT 100 APAC LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 101 APAC LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 102 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 103 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 104 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 105 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 106 INCREMENTAL GROWTH IN APAC (2022 & 2028)

EXHIBIT 107 INDIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 108 CHINA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 109 JAPAN LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 110 SOUTH KOREA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 111 AUSTRALIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 112 PHILIPPINES LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 113 LATIN AMERICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)

EXHIBIT 114 LATIN AMERICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 115 LATIN AMERICA LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)

EXHIBIT 116 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 117 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 118 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 119 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 120 INCREMENTAL GROWTH IN LATIN AMERICA (2022 & 2028)

EXHIBIT 121 BRAZIL LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 122 MEXICO LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 123 ARGENTINA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 124 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET: KEY COUNTRIES, 2022 ($ BILLION)

EXHIBIT 125 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 126 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET 2022–2028 ($ BILLION)

EXHIBIT 127 INCREMENTAL GROWTH BY PRODUCT (2022 & 2028)

EXHIBIT 128 INCREMENTAL GROWTH BY APPLICATION (2022 & 2028)

EXHIBIT 129 INCREMENTAL GROWTH BY TECHNIQUE (2022 & 2028)

EXHIBIT 130 INCREMENTAL GROWTH BY END-USER (2022 & 2028)

EXHIBIT 131 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA (2022 & 2028)

EXHIBIT 132 TURKEY LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 133 SAUDI ARABIA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 134 SOUTH AFRICA LATERAL FLOW ASSAY MARKET, 2022–2028 ($ BILLION)

EXHIBIT 135 GLOBAL LATERAL FLOW ASSAY MARKET: TECHNOLOGY EXPERTISE

EXHIBIT 136 GLOBAL LATERAL FLOW ASSAY MARKET: DOMINANCE ANALYSIS

EXHIBIT 137 ABBOTT: TOTAL ANNUAL REVENUE, 2019–2021 ($ BILLION)

EXHIBIT 138 ABBOTT: REVENUE SHARE BY DIAGNOSTICS SEGMENT, 2021 (%)

EXHIBIT 139 F. HOFFMANN-LA ROCHE: TOTAL ANNUAL REVENUE, 2019–2021 ($ BILLION)

EXHIBIT 140 THERMO FISHER SCIENTIFIC REVENUE, 2019–2021 ($ BILLION)

EXHIBIT 141 THERMO FISHER SCIENTIFIC REVENUE BY BUSINESS SEGMENTS, 2019–2021 ($ BILLION)

 

 

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015–2022

TABLE 3 AI-BASED LFA DEVICES

TABLE 4 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)

TABLE 5 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 (%)

TABLE 6 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)

TABLE 7 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 (%)

TABLE 8 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 ($ BILLION)

TABLE 9 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 (%)

TABLE 10 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)

TABLE 11 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 (%)

TABLE 12 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)

TABLE 13 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 (%)

TABLE 14 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

TABLE 15 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)

TABLE 16 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)

TABLE 17 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 (%)

TABLE 18 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)

TABLE 19 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 (%)

TABLE 20 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)

TABLE 21 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 (%)

TABLE 22 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)

TABLE 23 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 (%)

TABLE 24 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)

TABLE 25 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 (%)

TABLE 26 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)

TABLE 27 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 (%)

TABLE 28 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)

TABLE 29 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 (%)

TABLE 30 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

TABLE 31 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)

TABLE 32 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 33 F. HOFFMANN-LA ROCHE: MAJOR PRODUCT OFFERINGS

TABLE 34 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS

TABLE 35 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 36 QUIDEL: MAJOR PRODUCT OFFERINGS

TABLE 37 ABAXIS: MAJOR PRODUCT OFFERINGS

TABLE 38 ABINGDON HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 39 ABINGDON HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 40 ARBOR VITA: MAJOR PRODUCT OFFERINGS

TABLE 41 ASSURE TECH: MAJOR PRODUCT OFFERINGS

TABLE 42 ATOMO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 43 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 44 BD: MAJOR PRODUCT OFFERINGS

TABLE 45 BIOMÉRIEUX: MAJOR PRODUCT OFFERINGS

TABLE 46 BIOLYTICAL LABORATORIES: MAJOR PRODUCT OFFERINGS

TABLE 47 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS

TABLE 48 BIOSYNEX: MAJOR PRODUCT OFFERINGS

TABLE 49 CUPID: MAJOR PRODUCT OFFERINGS

TABLE 50 DIALAB: MAJOR PRODUCT OFFERINGS

TABLE 51 HUMAN GESELLSCHAFT FÜR BIOCHEMICA UND DIAGNOSTICA MBH: MAJOR PRODUCT OFFERINGS

TABLE 52 INTEC: MAJOR PRODUCT OFFERINGS

TABLE 53 J. MITRA & CO. PVT. LTD.: MAJOR PRODUCT OFFERINGS

TABLE 54 KHB: MAJOR PRODUCT OFFERINGS

TABLE 55 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 56 MERCK KGAA: MAJOR PRODUCT OFFERINGS

TABLE 57 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS

TABLE 58 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS

TABLE 59 NANJING SYNTHGENE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 60 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 61 PERKINELMER: MAJOR PRODUCT OFFERINGS

TABLE 62 PREMIER MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 63 QIAGEN: MAJOR PRODUCT OFFERINGS

TABLE 64 REGA BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 65 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS

TABLE 66 TÜRKLAB A. S: MAJOR PRODUCT OFFERINGS

TABLE 67 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS

TABLE 68 WONDFO: MAJOR PRODUCT OFFERINGS

TABLE 69 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 70 GLOBAL LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 71 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 72 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 73 EUROPE LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 74 EUROPE LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 75 APAC LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 76 APAC LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 77 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 78 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 79 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 ($ BILLION)

TABLE 80 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY PRODUCT, 2022–2028 (%)

TABLE 81 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 82 GLOBAL LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 83 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 84 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 85 EUROPE LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 86 EUROPE LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 87 APAC LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 88 APAC LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 89 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 90 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 91 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 ($ BILLION)

TABLE 92 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY TECHNIQUE, 2022–2028 (%)

TABLE 93 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 94 GLOBAL LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 95 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 96 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 97 EUROPE LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 98 EUROPE LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 99 APAC LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 100 APAC LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 101 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 102 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 103 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 ($ BILLION)

TABLE 104 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY APPLICATION, 2022–2028 (%)

TABLE 105 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 106 GLOBAL LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 107 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 108 NORTH AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 109 EUROPE LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 110 EUROPE LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 111 APAC LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 112 APAC LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 113 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 114 LATIN AMERICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 115 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 ($ BILLION)

TABLE 116 MIDDLE EAST & AFRICA LATERAL FLOW ASSAY MARKET BY END-USER, 2022–2028 (%)

TABLE 117 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY, 2022–2028 ($ BILLION)

TABLE 118 GLOBAL LATERAL FLOW ASSAY MARKET BY GEOGRAPHY, 2022–2028 (%)

TABLE 119 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 ($ BILLION)

TABLE 120 GLOBAL LATERAL FLOW ASSAY MARKET BY KITS & REAGENTS, 2022–2028 (%)

TABLE 121 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 ($ BILLION)

TABLE 122 GLOBAL LATERAL FLOW ASSAY MARKET BY READERS, 2022–2028 (%)

TABLE 123 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 ($ BILLION)

TABLE 124 GLOBAL LATERAL FLOW ASSAY MARKET BY CLINICAL DIAGNOSTICS, 2022–2028 (%)

TABLE 125 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 ($ BILLION)

TABLE 126 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD SAFETY, 2022–2028 (%)

TABLE 127 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 ($ BILLION)

TABLE 128 GLOBAL LATERAL FLOW ASSAY MARKET BY VETERINARY DIAGNOSTICS, 2022–2028 (%)

TABLE 129 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

TABLE 130 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)

TABLE 131 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 ($ BILLION)

TABLE 132 GLOBAL LATERAL FLOW ASSAY MARKET BY SANDWICH ASSAYS, 2022–2028 (%)

TABLE 133 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 ($ BILLION)

TABLE 134 GLOBAL LATERAL FLOW ASSAY MARKET BY COMPETITIVE ASSAYS, 2022–2028 (%)

TABLE 135 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 ($ BILLION)

TABLE 136 GLOBAL LATERAL FLOW ASSAY MARKET BY HOSPITALS & CLINICS, 2022–2028 (%)

TABLE 137 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 ($ BILLION)

TABLE 138 GLOBAL LATERAL FLOW ASSAY MARKET BY HOME HEALTHCARE, 2022–2028 (%)

TABLE 139 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 ($ BILLION)

TABLE 140 GLOBAL LATERAL FLOW ASSAY MARKET BY DIAGNOSTIC LABORATORIES, 2022–2028 (%)

TABLE 141 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 ($ BILLION)

TABLE 142 GLOBAL LATERAL FLOW ASSAY MARKET BY FOOD & BEVERAGE COMPANIES, 2022–2028 (%)

TABLE 143 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 ($ BILLION)

TABLE 144 GLOBAL LATERAL FLOW ASSAY MARKET BY PHARMA & BIOTECH COMPANIES, 2022–2028 (%)

TABLE 145 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 ($ BILLION)

TABLE 146 GLOBAL LATERAL FLOW ASSAY MARKET BY OTHERS, 2022–2028 (%)

Select a license type that suits your business needs

single-user Single User Licence
$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date